Active surveillance—repeated measurements of prostate specific antigen, digital rectal examination, and prostate biopsies—is an alternative treatment option to active therapy, such as radical prostatectomy or radiotherapy, for patients with low grade prostate cancer. This evidence concerns the gene KLK3 and prostate carcinoma.